Please login to the form below

Not currently logged in
Email:
Password:

Ariad appoints new board member

Alexander Denner is chief investment officer of Sarissa Capital Management
Ariad Alexander Denner

Ariad Pharmaceuticals has appointed Alexander Denner to the company's board of directors.

Denner is currently chief investment officer of investment firm Sarissa Capital Management and has served as senior managing director at Icahn Capital and as portfolio manager at both Viking Global Investors and Morgan Stanley Investment Management.

His pharma experience includes director roles at Biogen Idec and Vivus.

Ariad will look to benefit Denner's experience as it prepares to grow the market share of leukaemia drug Iclusig (ponatinib).

The drug was approved at the end of 2012 in the US and in 2013 in the EU, although later faced safety reviews in both regions after it was linked to the development of blood clots.

Both the FDA and EMA concluded that the drug should continue to be available although with updated safety information.

Ariad also announced that another director is due to join the board, bringing the total number of board members to 10.

25th February 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics